Patients treated in PCMH visit ER less, study finds

Chronically ill patients who are cared for in a patient-centered medical home model visit the emergency department less frequently, according to a study authored by Independence Blue Cross and CTI Clinical Trial and Consulting Services.

Advertisement

Researchers used claims data from about 460,000 Independence beneficiaries at 280 primary care offices. They found a 5 to 8 percent reduction in ED visits, specifically for patients with chronic illnesses who made one or more ED visits in a year. The reductions were most evident among diabetic patients, who saw a 9.5 to 12 percent reduction in ED visits.

The researchers tie this reduction in ED use to improved, more coordinated care provided by PCMHs that allows for better chronic disease management.

“Medical homes are particularly beneficial to…high-risk or chronically ill population[s] because of the added resources they receive, such as care managers and dieticians that provide regular outreach…about test reminders, preventive care and other information and support,” said Somesh Nigam, Independence’s senior vice president and chief informatics officer. “Care is also more coordinated and problems are addressed quickly so they don’t become worse and result in an emergency room visit or complication.”

More articles on PCMHs:
3 latest stories on patient-centered medical homes
NCQA patient-centered medical homes achieve better results than non-accredited counterparts
Geisinger Health expands on patient-centered medical home model

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Care Coordination

Advertisement

Comments are closed.